Literature DB >> 15164967

A Klebsiella pneumoniae producing three kinds of class A beta-lactamases encoded by one single plasmid isolated from a patient in Huashan Hospital, Shanghai, China.

Zizhong Xiong1, Demei Zhu, Fu Wang, Yingyuan Zhang, Ryoichi Okamoto, Matsuhisa Inoue.   

Abstract

A Klebsiella pneumoniae strain was isolated from a sputum specimen of a patient in the intensive care unit in 1999 in Shanghai Huashan Hospital, China. The isolate was confirmed as an extended-spectrum beta-lactamase (ESBL) producing strain by double-disk synergy test. The results of susceptibility test showed that it was resistant to most beta-lactams (including third generation cephalosporins) and non-beta-lactam antimicrobial agents. Transconjugants were obtained at a frequency of 10(-4). A plasmid of about 60 kb was obtained from the transconjugant by plasmid extraction. Three major nitrocefin-hydrolysing bands with pIs of 5.4, 8.2 and 8.4, were shown in extracts of the transconjugant. Partial gene amplification products of bla(TEM), bla(SHV), and CTX-M-1 group gene were obtained from the isolate as well as its transconjugant. The entire bla(TEM), bla(SHV), and bla(CTX-M) in the transconjugant were amplified by PCR and the PCR products were cloned into a pHSG398 vector. Afterwards, the susceptibility of transformants and activities of beta-lactamases of transformants on antibiotics were tested. The PCR products were directly sequenced, analysed and identified as TEM-1, SHV-12, and CTX-M-3 genes. These results confirm that this strain of Klebsiella pneumoniae produces SHV-12, CTX-M-3 ESBLs and TEM-1 beta-lactamase, encoded by one single plasmid, which is responsible for the resistance of this strain to most beta-lactams.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164967     DOI: 10.1016/j.ijantimicag.2003.07.011

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

1.  Phenotypic and Genotypic Methods for Detection of Extended Spectrum β Lactamase Producing Escherichia coli and Klebsiella pneumoniae Isolated from Ventilator Associated Pneumonia.

Authors:  Veena Krishnamurthy; Vijaykumar G S; Sudeepa Kumar M; Prashanth H V; Prakash R; Nagaraj E R
Journal:  J Clin Diagn Res       Date:  2013-09-10

2.  Phenotypic and molecular characterization of two novel CTX-M enzymes carried by Klebsiella pneumoniae.

Authors:  Jun Cheng; Wei Gao; Jun Yin; Zhen Sun; Ying Ye; Yu-Feng Gao; Xu Li; Jia-Bin Li
Journal:  Mol Biol Rep       Date:  2009-03-18       Impact factor: 2.316

3.  Interaction of CTX-M-15 enzyme with cefotaxime: a molecular modelling and docking study.

Authors:  Shazi Shakil; Asad Ullah Khan
Journal:  Bioinformation       Date:  2010-04-30

4.  A novel SHV-type beta-lactamase variant (SHV-89) in clinical isolates in China.

Authors:  Jia-Bin Li; Jun Cheng; Qian Wang; Yan Chen; Ying Ye; Xue-Jun Zhang
Journal:  Mol Biol Rep       Date:  2008-06-29       Impact factor: 2.316

5.  Molecular docking analysis of new generation cephalosporins interactions with recently known SHV-variants.

Authors:  Asad Ullah Khan; Mohd Hassan Baig; Gulshan Wadhwa
Journal:  Bioinformation       Date:  2011-01-22

6.  High Prevalence of Multidrug-Resistant Klebsiella pneumoniae Harboring Several Virulence and β-Lactamase Encoding Genes in a Brazilian Intensive Care Unit.

Authors:  Roumayne L Ferreira; Brenda C M da Silva; Graziela S Rezende; Rafael Nakamura-Silva; André Pitondo-Silva; Emeline Boni Campanini; Márcia C A Brito; Eulália M L da Silva; Caio César de Melo Freire; Anderson F da Cunha; Maria-Cristina da Silva Pranchevicius
Journal:  Front Microbiol       Date:  2019-01-22       Impact factor: 5.640

7.  High frequency of simultaneous presence of ESBL and carbapenemase producers among nosocomial coliform isolates in Faisalabad, Pakistan.

Authors:  Sofia Irfan; Aysha Azhar; Asad Bashir; Salman Ahmed; Abdul Haque
Journal:  Pak J Med Sci       Date:  2021 Jan-Feb       Impact factor: 1.088

8.  Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study.

Authors:  Shazi Shakil; Asad U Khan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-01-14       Impact factor: 3.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.